Font Size: a A A

Comparison Of The Epidermal Growth Factor Receptor Protein Expression Between Primary Non-small Cell Lung Cancer And Paired Lymph Node Metastases

Posted on:2012-03-23Degree:MasterType:Thesis
Country:ChinaCandidate:Z HuangFull Text:PDF
GTID:2154330335994018Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Objective:To compare the expression and consistency of the epidermal growth factor receptor protein between primary non-small cell lung cancer and paired lymph node metastases. Methods:Expression of EGFR was investigated immunohistochem-ically in paired samples of primary non-small cell lung cancer and corresponding lymph node metastases of 50 cases. Results:Positive (1+,2+or 3+) EGFR immuno-staining was evident in 37 of 47 (78.7%) analysed NSCLC primary tumors, and in 76.6% of the corresponding lymph node metastases(P>0.05); EGFR overexpression (2+or 3+) was found in 51.1%(24/47) of the NSCLC primary tumors and 48.9%(23/47) of the corresponding metastases (P>0.05); adenocarcinoma primary tumor and lymph node metastasis rate of EGFR overexpression was higher than squamous cell carcinoma(P< 0.05). EGFR was expressed negative,1+,2+or 3+ in Primary lesions, the lymph node metastasis report was also expressed negative,1+,2+ or 3+ of t32 cases (68.1%,32/47), EGFR expression have consistency, and moderate intensity (K=0.562, P=0.000). When EGFR expression was classified as positive or negative, discordance between the primary tumors and the corresponding metastases was observed inl4.9%(7/47):in 4 cases, EGFR was expressed in the primary tumor but not in the metastasis, while three samples showed EGFR expression in the metastasis but not in the primary tumor. Regarding EGFR overexpression, thirteen out of the 47paired samples (27.6%) were discordant for EGFR status between the primary site and the metastases:only 7 patients who had 2+ or 3+ in the primary tumors and changed to 0 or 1+ in lymph node metastases, and another six patients who had 0 or 1+ in the primary tumors and changed to 2+ or 3+ in lymph node metastases. Age> 59 years, adenocarcinoma and stage III NSCLC primary lesions and lymph node metastases consistency strength of a high degree of EGFR expression. Conclusion: primary non-small cell lung cancer and corresponding lymph node metastases have high expression of EGFR, EGFR overexpression is closely related with the pathological types of NSCLC:adenocarcinoma is higher than squamous cell carcinoma of EGFR overexpression; The EGFR expression of primary non-small cell lung cancer and corresponding lymph node metastases exist consistency; The EGFR expression of primary tumor and lymph node metastasis exists a high degree of consistency in age>59 years, adenocarcinoma and stageâ…¢NSCLC.
Keywords/Search Tags:EGFR, non-small cell lung cancer, primary tumors, lymph node metastases, Immunohistochemistry
PDF Full Text Request
Related items
Detection Of EGFR Mutations In NSCLC Tumor Specimens From Various Ways By DHPLC And Comparison Of EGFR And K-ras Genotypes Between Primary Tumors And Corresponding Lymph Node Metastases In NSCLC
Brain Metastases After Complete Resection Of Primary Tumor Of Non-Small Cell Lung Cancer:Research On Tumor Molecular Pathological Features And Clinically Concerned Problems
1.Predictors Of Lymph Node Metastasis And Possible Selective Lymph Node Dissection In Clinical Stage IA Non-Small Cell Lung Cancer 2.Expression And Significance Of Chemokine Receptor CCR7、CXCR4、CXCR5、CXCL13 In Stage T1 Non-small Cell Lung Cancer 3.Expe
Preoperative Prediction Of Lymph Node Metastasis In Non-Small Cell Lung Cancer Based On 18F-FDG PET/CT Radiomics
The Regularity And Clinical Analysis Of Intrapulmonary Lymph Node Metastasis In Non-small Cell Lung Cancer
A Pilot Study Of 18F-Alfatide PET/CT Imaging For Detecting Lymph Node Metastases In Patients With Non-Small Cell Lung Cancer
Clinical Significance Of PD-L1 Expression In Bone Metastases Of Non-small Cell Lung Cancer,EGFR Mutation And PD-L1 Expression In Bone Metastases And Heterogeneity Of Primary Lesions Of Lung Cancer
The Expression Of Aldehyde Dehydrogenase1in Invasive Primary Breast Tumors And Axillary Lymph Node Metastases Is Associated With Clinical Prognosis
PET-CT Imaging-based Preoperative Diagnosis Of Lymph Node Metastases In Non-small Cell Lung Cancer
10 SUVmax Ratio Of Mediastinal Lymph Node To Primary Tumor And To Liver In Dignosis Of Mediastinal Lymph Node Metastasis In Patients With Non-Small Cell Lung Cancer